This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Post #60 answers the question as asked. The question underneath it is different.
Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
I would be glad to be shown a cleaner way of putting this.
General information rather than advice about anyone's care. A single value outside a reference interval, on a single draw, in an otherwise unremarkable panel, is usually uninformative.
That distinction has done more work for me than anything else in this category.
Panel is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.
Adding the boring version of panel, because the interesting version keeps getting posted and the boring one is usually right.
Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.
Everything in post #62 holds. The case it does not cover is the one I have.
Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A single mid-course panel can be misleading.
The conclusion is tentative; the arithmetic underneath it is not.
Before the thread moves on from panel — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and from an n of four hundred.
Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated triglyceride with low HDL is different from triglyceride elevation alone.
Answering the question post #69 raises rather than the one it answers.
Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
The arithmetic in post #69 is right; the assumption feeding it is the part to check.
Summarising the panel thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.
Reading rather than answering, but this is the post I would point somebody at.
Nothing in this subcategory is medical advice, and a panel with an unexpected result is precisely the situation where that matters.
The rule of thumb is fine; the edge cases are where it earns its keep.
Narrowing post #73, because the general version has more than one answer.
Adding a reference point for panel. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
I have no financial interest in anything named in this thread and I want to say so before I comment on panel, because it is the sort of subject where it matters.
On panel I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get heated.
Where a panel includes a calculated value, that value inherits the imprecision of everything it was calculated from and is usually reported without an interval.
The evidence for this is thinner than the way I have phrased it suggests.
Worth separating two things that post #80 runs together.
Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is comparing things that are not the same.
If that reads as pedantic, it is, and it has saved me twice.
A note on how panel gets discussed rather than on panel itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.
I read post #84 twice before replying, because I had assumed the opposite.
Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
If it helps: the failure mode here is usually boring rather than dramatic.
That is a fair summary of where the discussion has got to.